Jefferson Journal of Psych iat ry dol (Haldol'") for the two months prior to admission. Her compl ian ce with these medications and with psychiatric outpatient therapy has been erratic.
Other than a history of a seizure disorder, this patient's past med ical history is remarkable for an appendectomy and for removal of sebaceous cysts. There is a past history of cigarette smoking not further quantified. The patient denied a ny history of alcohol abuse or abuse of illicit drugs. The family history is rem arkable for unspecified psychiatric disorders in the patient's mother and maternal great uncle.
At admission to the psychiatric service, she was a thin, dishe velled white fema le who appeared her stated age. She was wearing one bedroom slipper. Her right a rm a nd leg manifested a coarse resting tremor. Her speech was incoherent, often illogical, a nd frequently pressured and loud. Her affect was suspicious and hostile. The pat ient's thought content included paranoid delusions and a preoccupation with her seizu re disorder and her auditory hallucinations. She denied suicidal or homicidal idea tion. She was alert and oriented to person, place and time. No memory deficits were noted. Her ability to concentrate and abstract appropriately was impaired. Her insight a nd judgement were impaired .
The physical examination was remarkable for horizontal nystagmus, with the fast component to the left, decreased vibratory sensation in both legs, a nd mild atax ia. Hypertrichosis was noted. Pertinent laboratory examinations revealed a mild incr ease in her hemoglobin (I4.2), hematocrit (43.2) and mean corpu scular volume (97). SMA-12, thyroid function studies, urinalysis, chest X-ray, and electrocardiogram were all normal.
The patient's hospital course may be described as follows. She was admitte d to the psychiatric service on September 26th with elevated levels of phenobarbital a nd phenytoin. When the levels had decreased to within therapeutic range, these medications were restarted. Upon admission, the patient was also given Haldol e , which was titrated slowly upwards in order to avoid precipitating seizures. Although the patient complained of repeated seizures, none were ever observed by staff. Throughout her hospitalization the patient remained psychotic, preoccupied with the idea that laser beams were controlling her, despite dosages of haloperidol to 80 mgs per da y. Th e patient frequently displayed angry outbursts. After a neurologic consultation was obtained, the patient was started on a course of carbamazepine (Tegretolv). At that time, the patient's phenobarbital, phenytoin, and haloperidol were titrated downward s. However, the patient's psychosis worsened and her haloperidol was retitrated up to 80 mgs per day . There was marked difficulty in obtaining therapeutic serum levels of carbamazepine, which was thought to be a result of the induction of the micro somal enzyme system by phenobarbital and phenytoin. As the patient received incr easing doses of carbamazepine, she began to exhibit prominent ataxia, intention tremors and a positive Romberg Sign. (At this time the patient arrived to be interviewed There is a subgroup of pat ients with partial complex seizures who develop a schizophrenic-like psychosis. If this pa tient' s history is correct, then she may be a part of thi s subgroup. T ypicall y, this psychosis occu rs approximately fifteen year s after the onset of th e seizure disord er. Another issue is how to treat thi s patient if she is indeed a part of th is subgroup. It has been demonstrated that when one controls the seizure disorder, the psychosis worsens, and that when one controls the psychosis, the seizure disorder worsens. With this in mind, we must ask ourselves what would be the safest neuroleptic to use in the light of evidence that neuroleptics can lower the seizure threshold. First, I would like to ask Dr. Streletz from the TJUH Department of Neurology to discuss the EE G findings. Dr. Streletz: Although the EEG may support the diagnosis of partial complex seizures, this diagnosis is primarily based on clinical findings . For this reason , I would like to ask Dr. Bertoni to speak about the clinical aspects of partial compl ex seizures before discussing the EEG findings. Dr . Bertoni: The first que stion that I always have regards the nature of the patient' s spells . Often, these patients are poor historians. The most importa nt evidence often must come from eye-witness accounts. Although the patient may not remember the seizure, per se, he may remember having a sore tongue or wet pants. If such evidence can be obt a ined in th e absence ofsubstance abuse or withdrawal. then one may suspect the presence of a recurring grand mal seizure disorder. As far as pa rti al complex seizures are concerned, history is equ ally important. W e like to have evidence of some phenomenon that is of temporal lobe origin, for example, olfactory hallucinati ons a nd deja vu experiences. Once a complete history is obtained, an attempt is mad e to classify the seizure disorder, not simply for the neatness of cla ssifying them, but because the prognosis and treatment ma y depend on this differentiation. We also want to know whether or not the pati ent was taking a ny drugs that migh t lower the seizure threshold .
In addition, what were the conditions under which the seizure occurred ? For example, sleep deprivation or drug therapy can lower the seizure threshold. Fina lly, is the patient compliant with the tre atment regimen that has been established for his seizure disorder? Once all of thi s information has been obt ained , we seek corro borative evidence in tests such as EEGs and CT scans. Dr. Dubin: Dr. Bertoni, it has been my impression from the literature that violence is rarely a consequence of partial complex seizures. Would you agree with th is? Dr. Bertoni: My belief is that almost anything is possible in an epileptic seizure. However, goal-directed violent behavior is extremely rare and very difficu lt to document. What most often happens is tha t in the peri od following a seizure these patients are bombarded with stimuli from bystanders who may be trying to help, for example, by restraining them, and they subsequently become comb ative. Dr. Streletz: I agree with Dr. Bertoni that violent behavior a mong epileptic patients is most commonly seen in the post-ict al period. I am reminded of Dr . Fa ulkner's stu dy of temporal lobe epileptics who had a history of aggressive and violent episodes ( I) . Most of these patients were schizophrenic and were found to have organic pathology on histological exams, at the time of temporal lobectomy. Th at is to say, small A-V malformations, mesiotemporal sclerosis , low-grade gliomas, or hamartomas of the temporal lobe were found in the resected tissue . The behavioral abnormalities improved after resection. This should help us understand that temporal lobe epilepsy is not a disease in a nd of itself, but rather a symptom of und erl ying pat hology. Th e EEG may be helpful in locali zing the source of thi s pathology, but rar ely the precise etio logy.
Looking at this patient's EEG, we can see a righ t antero to mid tempora l focus of sharp waves and spike activity associated with some slowing in that a rea . In this Jefferson Jo urnal of Psychiatry patient, it is best demonstra ted during sleep, a n event which often activates inte rictal epileptifor m ac tivity . Th e persistent slowing th at is seen throughout th is patient's recording, that is to say, a delt a focus in association with the noted epilept ifor m activity, ma y suggest a n underlying structura l lesion. Otherw ise, the epileptic spike is probably ari sing from disordered syna ptic fun ction in the tem poral lobe, an event tha t is correlated with partial complex seizures. Dr. Bert oni: Ho w do you distinguish the changes you've noted from the effects of medic ation such as phenothiazin es? Dr. Strelet z: Drug effects commonly cau se genera l cha nges in the EEG without localization, generall y in the beta frequency . When benzodiazepenes ar e used, one induces excess high-amplitude fast activity in the front al regions. Thi s pati ent' s background activity is not disorganized; there is no evide nce of excessive fast or slow ac tivity. Her recording is essenti ally remarkab le for the seizure focus described. Dr . Dubin: Wh at perc ent age of pati ent s with partial complex seizu res have EEGs tha t are actually within normal limits? Dr . Streletz: With sta nda rd EEG electro de placement, a pproxima tely ten perce nt of these pati ent s may have a norm al EEG . With more specialized electrode place ment, however , these patie nts ca n sometimes be shown to have a seizure focus in the temporal lobe. An example of thi s is the placem ent of electrodes in the nasopha ryngeal region (approximately 20 mm from the temporal lobe). Video-EEG cor relation may also be useful in helping to identify these pa tients, particul arl y pat ients who are thought to have psychiatric disord ers, becau se th eir EEGs a nd behavior may be simulta neously monitored. Dr . Dub in: May we examine the CT sca n? Dr . Bertoni: The CT scan was done after th e patient had been in the hospit al for a pproxima tely one month. We can see that there is a littl e more spa ce around the cerebellum th a n is norm all y seen a nd the four th ventricle may be slightly la rger than norm al , but looking a t the temporal lobes there is no evidence of a bnormality. On the contrast-enhanced study, no temporal lobe lesions a re seen either. The extra space around the patient's cerebellar vermi s, however , may correla te with her mild clinical feelings of midline ataxia. Finall y, there is some calcificat ion of the basal gangl ia and choroid plexus noted th at is not of clinical sign ifica nce in thi s patient. Dr . Dubin: Let us turn to a discussion of possib le psychophar macologica l approach es to thi s patient. Dr. Ingalls, Clinical Psychopharmacolog ist : The tre atment of pa tients with both seizure disorders a nd psychosis can be extremely difficult. Th er e is relatively litt le literature on th is subject becau se the number of studies on sufficiently large patient population is sma ll. Th e most recent study is based on dru g infusions of the guinea pig hippocampus to elicit seizure act ivity, using thi s as a model for hum an seizure activity. This study, publi shed in the Archives of General Psychiatry (2) , refut es an earlier study in lAMA (3) wher e the epileptic side effects of va rious psychotropics were studied, with a rating given to each psychotropic based on their propensity to cau se seizures. These ratings a re based chiefly on literature review. Wh ile these findings may be controversial, it is known that all a ntipsychotics ca n lower the seizure threshold.
Thi s knowledge is of gre atest value in the patient who had a known seizure disorder. These pat ient s must always be adequa tely tre ated with a nticonvulsant medication before psychotropics are begun. Dr. Dubin: Are some anti psychotics safer than others? Dr. Ing alls: General references (4) seem to suggest that high potency neuroleptics may be safer, but there are reall y no scientific studies to support th at. Dr. Dubin: Dr . Bertoni, one of the finding s seen in th is pa tient was consistent with cerebellar degeneration. How comm on is cerebellar degenerati on in patients who are receiving Dilantin®? Dr. Bertoni: In my practice, I a m careful to monitor tand em gait becau se once I start seeing problems with th at test , especiall y if the serum level of Dilantinw is in the therapeutic range, I consider switching to another a nticonvulsant medicine. Some cerebellar ataxia is frequently encountered in patients who have received Dilantinv over a long period of time. Dr. Dubin: Which medicine would you switch the patient to ? Dr. Bertoni: In most cases, if there is an adequate history to support the diagnosis of temporal lobe epilepsy, the drug of choic e may not be phenytoin, but ca rbamazepine. Dr . Dubin: Are you convinced that this patient has partial com plex seizures? Dr . Bertoni: I must say , I always have doubts, especi all y in patients who provide very little reliable information. I think that our first responsibility is to do the least harm possible. Onl y after careful evalu ation of the risk-benefit ra tio should we proceed with a course of therapy. In thi s patient, we do have some history of tongue biting a nd loss of bladder control, as well as EEG evidenc e to support the diagnosis of a seizure disorder, th e source of which is the temporal lobe. Dr. Ingall s: Often the qu estion a rises in the ac ute psychot ic patient who needs relativel y large dosage s of a ntipsychot ics if there is a ny benefit from temporarily increas ing their dosage of anticonvulsant medication to obt ain supra therapeutic levels. Could you comment on thi s? Dr. Bertoni : Well , I thi nk if the level is with in th e norm al range for therapeutic efficac y, you probably don 't need an y more , although this level may need to be near the high end of the range. There is some evidence in the older litera ture to suggest that supra ma ximal or toxic levels ma y in fact have an adverse effect. As an aside, here, I'd like to make a plea that when you measure serum levels of anticonvulsan t medicat ions, what you want to measure is the trough level, that is to say, the seru m level preceding the next dose. Also, while the levels that we measure are typ icall y the total (fr ee plus bound) serum level of these drugs, special studies like free levels ma y be necessa ry in those patients whose protein binding has been altered . Finall y, clinic al response is always more important than the numbers. Dr. Dubin: From a psychi atric standpoint, patients with partial compl ex seiz ures with concomitant psychosis can manifest almost every symptom commonly seen in schizophrenia. The most common presenting symptoms ha ve been reported to be par anoia a nd a uditory hallucinations. Possible clues to a differential diagnosis between prima ry schi zophrenia and a schizophrenic-like psychosis that may result from partial complex seizures include the patient's degree of relatedness a nd a ny history of premorbid
